We are live on
!
Find out more
IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.89B
1-Year Est. Return
118.48%
This Fund
S&P 500
1 Year Est. Return
+118.48%
AUM
$1.89B
AUM Growth
-$83.2M
(-4.2%)
Holding
110
Top Buys
| 1 | +$38.4M | |
| 2 | +$30.3M | |
| 3 | +$29.5M | |
| 4 |
Boston Scientific
BSX
|
+$26M |
| 5 |
Merck
MRK
|
+$20.2M |
Top Sells
| 1 | +$64.8M | |
| 2 | +$37.9M | |
| 3 | +$31.2M | |
| 4 |
Penumbra
PEN
|
+$31.1M |
| 5 |
Teleflex
TFX
|
+$30.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CVS Health
CVS
$124B
| $10.8M | 0.57% |
150,000
-350,000
|
|
||
52
Cooper Companies
COO
$13B
| $10.7M | 0.57% |
150,000
-175,000
|
|
||
53
Thermo Fisher Scientific
TMO
$175B
| $9.83M | 0.52% |
+20,000
|
|
||
54
LivaNova
LIVN
$4.11B
| $9.53M | 0.5% |
+150,000
|
|
||
55
Lantheus
LNTH
$6.51B
| $9.48M | 0.5% |
125,000
+25,000
|
|
||
56
Tango Therapeutics
TNGX
$4.47B
| $9.41M | 0.5% |
450,000
+250,000
|
|
||
57
Ionis Pharmaceuticals
IONS
$12.2B
| $9.39M | 0.5% |
+125,000
|
|
||
58
Sana Biotechnology
SANA
$749M
| $9.22M | 0.49% |
3,200,000
+200,000
|
|
||
59
Celcuity
CELC
$4.26B
| $9.13M | 0.48% |
80,000
|
|
||
60
Protara Therapeutics
TARA
$227M
| $9.12M | 0.48% |
1,750,000
-500,000
|
|
||
61
Envista
NVST
$3.81B
| $8.88M | 0.47% |
350,000
-150,000
|
|
||
62
Biohaven
BHVN
$1.67B
| $8.46M | 0.45% |
1,000,000
-500,000
|
|
||
63
Syndax Pharmaceuticals
SNDX
$1.5B
| $8.18M | 0.43% |
350,000
+150,000
|
|
||
64
Viking Therapeutics
VKTX
$3.39B
| $8.13M | 0.43% |
250,000
+150,000
|
|
||
|
DFTX
65
Definium Therapeutics
DFTX
$2.51B
| $7.56M | 0.4% |
400,000
+50,000
|
|
||
66
Beam Therapeutics
BEAM
$3.06B
| $7.15M | 0.38% |
300,000
-250,000
|
|
||
67
Rezolute
RZLT
$393M
| $6.1M | 0.32% |
2,000,000
|
|
||
68
Capricor Therapeutics
CAPR
$1.51B
| $6.08M | 0.32% |
+200,000
|
|
||
69
IQVIA
IQV
$30.7B
| $5.97M | 0.32% |
+35,000
|
|
||
70
Axsome Therapeutics
AXSM
$12.1B
| $5.92M | 0.31% |
+35,000
|
|
||
71
Protagonist Therapeutics
PTGX
$6.3B
| $5.27M | 0.28% |
+50,000
|
|
||
|
EVMN
72
Evommune Inc
EVMN
$727M
| $5.17M | 0.27% |
225,000
+100,000
|
|
||
73
Acadia Healthcare
ACHC
$2.33B
| $4.68M | 0.25% |
+200,000
|
|
||
74
Zimmer Biomet
ZBH
$16.9B
| $4.52M | 0.24% |
+50,000
|
|
||
75
Forte Biosciences
FBRX
$321M
| $3.88M | 0.21% |
+150,000
|
|